FDA Approves Bristol-Myers Squibb Late-Stage Breast Cancer Drug Ixempra

An FDA spokesperson on Tuesday said the agency approved Bristol-Myers Squibb’s chemotherapy drug Ixempra for use as a breast cancer treatment for women who have not responded to other treatments, as well as for use in combination with [click link for full article]

More: continued here

Filed under: Breast Cancer on October 20th, 2007